title: Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus.
abstract: The purpose of this study was to examine the frequency of alpha-thalassemia in the population of Cyprus using cord blood samples. The levels of Hb Bart's were compared with the hematological indices and the results correlated with the presence of alpha-thalassemia mutations. The protocols for the polymerase chain reaction detection of the six most common alpha-globin mutations encountered in Cyprus were optimized, and the frequency of each mutation was determined through the screening of 495 random cord blood samples. The total allele frequency for the mutations examined was 10.6%, of which 1% is due to the triplication of the alpha-globin genes. The -alpha(3.7 kb) deletion accounts for 72.8% of all detectable mutations, while the--MED-I and -(alpha)-20.5 kb mutations account for 7.8%. The level of Hb Bart's and the MCV and MCH values in cord blood samples were found to correlate closely with the severity of alpha-thalassemia, although the -alpha(3.7 kb) deletion and perhaps other mild alpha-thalassemia mutations may not give detectable Hb Bart's levels. A reasonably accurate estimate of the alpha-thalassemia carrier frequency may be obtained from cord blood studies if Hb Bart's estimates are combined with hematological indices. When molecular methods are added, these give the best way to use cord bloods to survey populations for alpha-thalassemia.
authors.affiliation: The Cyprus Institute of Neurology and Genetics, Nicosia.
authors.forename: K
authors.initials: K
authors.lastname: Kyriacou
authors.forename: A
authors.initials: A
authors.lastname: Kyrri
authors.forename: E
authors.initials: E
authors.lastname: Kalogirou
authors.forename: P
authors.initials: P
authors.lastname: Vasiliades
authors.forename: M
authors.initials: M
authors.lastname: Angastiniotis
authors.forename: P A
authors.initials: PA
authors.lastname: Ioannou
authors.forename: M
authors.initials: M
authors.lastname: Kleanthous
mesh_terms: D000483:Alleles; D003535:Cyprus / Q000453:epidemiology; D004252:DNA Mutational Analysis; D004909:Erythrocyte Indices; D005312:Fetal Blood / Q000737:chemistry*; D005787:Gene Frequency; D005820:Genetic Testing; D005838:Genotype; D005914:Globins / Q000235:genetics; D006400:Hematocrit; D006403:Hematologic Tests; D006455:Hemoglobins, Abnormal / Q000009:adverse effects / Q000235:genetics / Q000378:metabolism*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D009154:Mutation / Q000235:genetics*; D017085:alpha-Thalassemia / Q000097:blood / Q000453:epidemiology / Q000235:genetics*
chemical_list: D006455:Hemoglobins, Abnormal; D005914:Globins; C030448:hemoglobin Bart's